Sponsored The evolution of cellular immunotherapy: From transplant to CAR T cells October 03, 2025Vol.51 No.36By Stephen J. Forman
News AnalysisRegulatory News Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autismExperts call the move “extremely premature” September 26, 2025Vol.51 No.35By Claire Marie Porter and Paul Goldberg
Guest Editorial Population-based cancer surveillance is a national treasure at risk September 26, 2025Vol.51 No.35By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash
Sponsored Ci4CC’s 24th Symposium & Workshop set to focus on precision oncology powered by data intelligence September 26, 2025Vol.51 No.35By Stephen D. Nimer
Trials & Tribulations Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology September 26, 2025Vol.51 No.35By Hardeep Phull
Guest Editorial Championing nurse wellbeing as a strategic priority September 26, 2025Vol.51 No.35By Kim Slusser
FreeIn the Archives Michael Link reflects on his ASCO presidential term, concerns for the future of oncology—and hope for children with cancer September 26, 2025Vol.51 No.35
NCI Anthony G. Letai to be named NCI directorThe Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say September 25, 2025Vol.51 No.35By Claire Marie Porter and Paul Goldberg
NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium September 19, 2025Vol.51 No.34By Paul Goldberg
NCI NCI releases names of members of ad hoc working group—filling the void left by BSA September 19, 2025Vol.51 No.34By Sara Willa Ernst
